Autonomix Medical

Autonomix (Nasdaq: AMIX) is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and...

Peripheral nervous system,breakthrough technology,nerve signaling,and precision-guided therapy

Autonomix medical operates in the Biotechnology research industry.

Autonomix medical's revenue is 11m - 100m

Autonomix medical has 11 - 50 employees.